1 OMEPRAZOLE | 2680 of 1,1970 | 900 prescriptions Less than 1% of all prescriptions | | 380 patients 9% of all patients | < 11 | |
2 AZATHIOPRINE | 70 of 2440 | 470 prescriptions Less than 1% of all prescriptions | | 150 patients 3% of all patients | < 11 | |
3 FAMOTIDINE | 970 of 4330 | 360 prescriptions Less than 1% of all prescriptions | | 190 patients 4% of all patients | < 11 | |
4 LIALDA (MESALAMINE) | 290 of 2070 | 300 prescriptions Less than 1% of all prescriptions | | 110 patients 2% of all patients | < 11 | |
5 URSODIOL | 550 of 3610 | 250 prescriptions Less than 1% of all prescriptions | 250 | < 11 | < 11 | |
6 PANTOPRAZOLE SODIUM | 2810 of 1,1170 | 270 prescriptions Less than 1% of all prescriptions | 270 | < 11 | < 11 | |
7 ENTECAVIR | 660 of 2210 | 190 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
8 RANITIDINE HCL | 1770 of 6500 | 110 prescriptions Less than 1% of all prescriptions | 110 | < 11 | < 11 | |
9 BACLOFEN | 130 of 520 | 300 prescriptions Less than 1% of all prescriptions | 300 | < 11 | < 11 | |
10 ADEFOVIR DIPIVOXIL | 30 of 170 | 230 prescriptions Less than 1% of all prescriptions | 230 | < 11 | < 11 | |
11 MESALAMINE | 390 of 4060 | 200 prescriptions Less than 1% of all prescriptions | 200 | < 11 | < 11 | |
12 HUMIRA PEN (ADALIMUMAB) | 300 of 1770 | 130 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
13 GAVILYTE-C (PEG3350/SOD SULF,BICARB,CL/KCL) | 500 of 3240 | 1260 prescriptions Less than 1% of all prescriptions | | 1250 patients 28% of all patients | < 11 | |
14 PEG 3350-ELECTROLYTE (PEG3350/SOD SULF,BICARB,CL/KCL) | 210 of 3030 | 1500 prescriptions Less than 1% of all prescriptions | 1380 | 1490 patients 34% of all patients | 1370 patients 31% of all patients | |
15 ONDANSETRON ODT (ONDANSETRON) | 270 of 1450 | 160 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
16 GOLYTELY (PEG3350/SOD SULF,BICARB,CL/KCL) | 20 of 40 | 120 prescriptions Less than 1% of all prescriptions | 120 | 120 patients 3% of all patients | 120 patients 3% of all patients | |